Standardised Frankincense extract: new possible therapeutic option for patients with relapsing-remitting multiple sclerosis

Oral standardized frankincense extracts could open a new therapeutic era in treatment of relapsing-remittingmultiple sclerosis patients

Over the last 20 years, the treatment landscape of relapsing-remitting multiple sclerosis (RRMS) has impressively changed and new oral first-line agents have been licensed. Indeed, from a complete lack of any treatment, neurologists have gone to drugs that are increasingly effective but which are associated with significant risks that can affect the survival of their patients. Neurologist specialised in the treatment of MS have to expand their medical skills and become familiar with haematological, cardiac, hepatic, renal and endocrine adverse events which were reported with the use of newer treatments now available. Neurologists must also become aware of the risk of opportunistic infections (progressive multifocal leucoencephalitis by natalizumab or other disease-modifying drugs)1 and other infectious complications, which, taken together and put on the complex process regarding therapy choice for patients with MS, dramatically increase...

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2BFXbQg